Evidence map›Paper›PMID 38688959›Full record

ArticleScientific reports2024

Polyphosphate and tyrosine phosphorylation in the N-terminal domain of the human mitochondrial Lon protease disrupts its functions.

Nina Kunová, Gabriela Ondrovičová, Jacob A Bauer, Veronika Krajčovičová, Matyáš Pinkas, Barbora Stojkovičová, Henrieta Havalová, Veronika Lukáčová, Lenka Kohútová, Július Košťan and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Nina Kunová *Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.
Gabriela Ondrovičová *Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.
Jacob A BauerDepartment of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.
Veronika KrajčovičováDepartment of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.
Matyáš PinkasCEITEC, Masaryk University in Brno, Brno, Czech Republic.
Barbora StojkovičováDepartment of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.
Henrieta HavalováDepartment of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.
Veronika LukáčováMedirex Group Academy, Nitra, Slovakia.
Lenka KohútováInstitute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.
Július KošťanDepartment of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Campus Vienna, Biocenter 5, 1030, Vienna, Austria.
Lucia MartinákováDepartment of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.
Peter BaráthMedirex Group Academy, Nitra, Slovakia.
Jiří NováčekCEITEC, Masaryk University in Brno, Brno, Czech Republic.
Sebastian ZollInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo Namesti 542/2, 16000, Prague, Czech Republic.
Sami KereïcheInstitute of Biology and Medical Genetics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. skere@lf1.cuni.cz.
Eva KutejováDepartment of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia. eva.kutejova@savba.sk.
Vladimír PevalaDepartment of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia. vladimir.pevala@savba.sk.
Institute of Molecular Biology of the Slovak Academy of Sciences · SKMasaryk University · CZMedirex Group Academy · SKSlovak Academy of Sciences · SKCharles University · CZCzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry · CZInstitute of Chemistry of the Slovak Academy of Sciences · SKUniversity of Vienna · AT

Funding

Agentúra na Podporu Výskumu a Vývoja APVV-15-0375, APVV-19-0298European Regional Development Fund BIOMEDIRES - II. stage, ITMS: 313011W428European Regional Development Fund, European Union UP CIISB (No. CZ.02.1.01/0.0/0.0/18_046/0015974)Grantová Agentura České Republiky 894 Grant No. 1825144YInterreg StruBioMol, ITMS: 305011X666Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 2/0069/23
6 · The paper itself

Abstract

Phosphorylation plays a crucial role in the regulation of many fundamental cellular processes. Phosphorylation levels are increased in many cancer cells where they may promote changes in mitochondrial homeostasis. Proteomic studies on various types of cancer identified 17 phosphorylation sites within the human ATP-dependent protease Lon, which degrades misfolded, unassembled and oxidatively damaged proteins in mitochondria. Most of these sites were found in Lon's N-terminal (NTD) and ATPase domains, though little is known about the effects on their function. By combining the biochemical and cryo-electron microscopy studies, we show the effect of Tyr186 and Tyr394 phosphorylations in Lon's NTD, which greatly reduce all Lon activities without affecting its ability to bind substrates or perturbing its tertiary structure. A substantial reduction in Lon's activities is also observed in the presence of polyphosphate, whose amount significantly increases in cancer cells. Our study thus provides an insight into the possible fine-tuning of Lon activities in human diseases, which highlights Lon's importance in maintaining proteostasis in mitochondria.

Indexed as

MitochondriaPolyphosphatesProtease LaTyrosineCryoelectron MicroscopyHumansPhosphorylationProtein DomainsPolyphosphatesProtease LaTyrosine

Identifiers

PMID38688959
PMCPMC11061198
OpenAlexW4396494974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.